Guilherme C. de Oliveira
  • Biochemistry


MD, Universidade Federal do Parana, Brazil, 2014

Current position

Resident, Surgery, Mayo Clinic, USA


  1. Tarrago, M. G., Chini, C. C. S., Kanamori, K. S., Warner, G. M., Caride, A., de Oliveira, G. C., Rud, M., Samani, A., Hein, K. Z., Huang, R., Jurk, D., Cho, D. S., Boslett, J. J., Miller, J. D., Zweier, J. L., Passos, J. F., Doles, J. D., Becherer, D. J. and Chini, E. N. (2018). A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD(+) Decline. Cell Metab 27(5): 1081-1095 e1010.
  2. Chini, E. N., Chini, C. C. S., Espindola Netto, J. M., de Oliveira, G. C. and van Schooten, W. (2018). The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging. Trends Pharmacol Sci 39(4): 424-436.
  3. Abreu-Reis, P., Oliveira, G. C., Curtarelli de Oliveira, A., Sadique, H., Nasr, A. and Saavedra Tomasich, F. D. (2012). Extra-curricular supervised training at an academic hospital: is 200 hours the threshold for medical students to perform well in an emergency room? World J Emerg Surg 7 Suppl 1: S12.